Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 6272309Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2025 award categories
- BIOLOGY
NIH Funding · FY2025
Linked Award Amount
$1.6M
Full award amounts, FY2025
Award Records
2
Records listing this PI
Award-Linked Rank
#9,581
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Jason W. Botten as a PI. Multi-PI records show the full award amount for context.
- 5R42AI132047-05R42A human monoclonal antibody therapy for treatment of hantavirus cardiopulmonary syndrome$955.9Kaward amount
- 5R01AI171408-04R01The role of mammarenavirus defective interfering particles in protecting host fitness and the host-driven post-translational modifications that regulate their formation and function$598.3Kaward amount
Award organizations
Organizations that administered FY2025 awards listing Jason W. Botten as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardCeldara Medical, Llc
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #7735
- 2024R01 Grant Holder
- 2025$2M Cumulative Funding
- 2025Multi-Institutional ResearchAwards at 2 institutions
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Jason W. Botten.